Suzetrigine for osteoarthritis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Also followed for narrower conditions: Osteoarthritis, Knee

Why this status

  1. 22 Oct 2025: Trial registered, NCT07219888
  2. 9 Feb 2026: Trial started, NCT07219888

The trials

NCT07219888: Comparison of Suzetrigine and Oxycodone for Postoperative Pain After Primary Total Knee Arthroplasty

State
Under way
Phase
Phase 4
People
140 planned
Started
9 Feb 2026
Primary completion
31 Dec 2026
Arms
Group A: suzetrigine group
Results
None posted
  1. 22 Oct 2025: Trial registered
  2. 9 Feb 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Journavx, Suz, Suzetrigine (Journavx), Suzetrigine (SUZ), Suzetrigine Group, oral suzetrigine.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.